Skip to content

Kewaunee Scientific Corporation KEQU Debt - Unamortized Discount (Premium) and Issuance Costs, Net

Debt - Unamortized Discount (Premium) and Issuance Costs, Net at other companies

UCT
Ultra Clean HoldingsUCTT
$17.5M
AVT
AvantorAVTR
$19.6M-3.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNet.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net?
Kewaunee Scientific Corporation (KEQU) reported debt - unamortized discount (premium) and issuance costs, net of $400K in Q4 2025.
How has Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net decreased by 33.8% year-over-year, from $604K to $400K.
What is the long-term trend for Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net?
Over 3 years (2022 to 2025), Kewaunee Scientific Corporation's debt - unamortized discount (premium) and issuance costs, net has grown at a 1.4% compound annual growth rate (CAGR), from $768K to $800K.
What does debt - unamortized discount (premium) and issuance costs, net mean?
This represents the net adjustment to the face value of debt, accounting for original issue discounts, premiums, and capitalized debt issuance costs. These amounts are amortized over the life of the debt instrument to reflect the effective interest rate. It is essential for reconciling the carrying value of debt to its face value.